Intuitive Surgical (ISRG) Receives FDA Letter Following Facility Inspection
Tweet
Share
E-mailGet Alerts ISRG Hot Sheet
Join SI Premium – FREE
Intuitive Surgical (Nasdaq: ISRG) shares are lower in late trading Tuesday following FDA issuance of a list of observations made during inspection of its California facility.
Several observations include changes being made without notification.
For a link to the pdf document, click here.
Several observations include changes being made without notification.
For a link to the pdf document, click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Genmab's Rina-S shows 45.9% response rate in ovarian cancer trial
- J&J releases 2-year icotrokinra data for hard-to-treat plaque psoriasis
- Century Therapeutics shares nonclinical data for iPSC-derived diabetes therapy
Create E-mail Alert Related Categories
FDA, Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
